chemotherapies.! New! candidates! for! therapy! have! been! identified! which! will! need! to!
translate!into!patient!care,!with!the!aim!to!improve!patient’!outcome.!!
(
References(:(
>! Swerdlow! S,! Campo! E,! Harris! N.L! et! al.! WHO! Classification! of! Tumours! of! Haematopoietic! and!
Lymphoid!Tissues!(IARC!WHO!Classification!of!Tumours).!vol.!2.!Revised!4th!edition.!2017!
>! Swerdlow! S,! Campo! E,! Pileri! SA! et! al.! The! 2016! revision! of! the! World! Health! Organization!
classification! of! lymphoid! neoplasms.! Blood.! 2016;127(20):2375>2390.>! Gaulard! P,! de! Leval! L.!
Pathology!of!peripheral!T>cell!lymphomas:!where!do!we!stand?!Semin!Hematol.!2014!Jan;51(1):5>16.!
>!Lemonnier!F,!Gaulard!P,!de!Leval!L.!New!insights!in!the!pathogenesis!of!T>cell!lymphomas.!Curr!Opin!
Oncol.!2018!Sep;30(5):277>284.!
>!Bachy!E,!Broccoli!A,!Dearden!C,!de!Leval!L,!Gaulard!P,!Koch!R,!Morschhauser!F,!Trümper!L,!Zinzani!
PL.! Controversies! in! the! Treatment! of! Peripheral! T>cell! Lymphoma.! Hemasphere.! 2020! Sep!
1;4(5):e461.!
>! Cortes! JR,! Ambesi>Impiombato! A,! Couronné! L,! et! al.! RHOA! G17V! Induces! T! Follicular! Helper! Cell!
Specification!and!Promotes!Lymphomagenesis.!Cancer!Cell.!2018!Feb!12;33(2):259>273!
>!Dobay!MP,!Lemonnier!F,!Missiaglia!E,!et!al.!Integrative!clinicopathological!and!molecular!analyses!of!
angioimmunoblastic! T>cell! lymphoma! and! other! nodal! lymphomas! of! follicular! helper! T>cell! origin.!
Haematologica.!2017!Apr;102(4):e148>e151.!
>!Laurent!C,!Baron!M,!Amara!N,!et!al.!Impact!of!Expert!Pathologic!Review!of!Lymphoma!Diagnosis:!
Study!of!Patients!From!the!French!Lymphopath!Network.!J!Clin!Oncol.!2017!Jun!20;35(18):2008>2017.!
>! Parrilla! Castellar! ER,! Jaffe! ES,! Said! JW,! et! al.! ALK>negative! anaplastic! large! cell! lymphoma! is! a!
genetically! heterogeneous! disease! with! widely! disparate! clinical! outcomes.! Blood.! 2014! Aug!
28;124(9):1473>80.!
>!Luchtel!RA,!Dasari!S,!Oishi!N,!et!al.!Molecular!profiling!reveals!immunogenic!cues!in!anaplastic!large!
cell!lymphomas!with!DUSP22!rearrangements.!Blood.!2018!Sep!27;132(13):1386>1398.!
>!Onaindia!A,!de!Villambrosía!SG,!Prieto>Torres!L,!et!al.!DUSP22>rearranged!anaplastic!lymphomas!are!
characterized! by! specific! morphological! features! and! a! lack! of! cytotoxic! and! JAK/STAT! surrogate!
markers.!Haematologica.!2019!Apr;104(4):e158>e162.!
>! Luchtel! RA,! Zimmermann! MT,! Hu! G,! et! al.! Recurrent! MSC! E116K! mutations! in! ALK>negative!
anaplastic!large!cell!lymphoma.!Blood.!2019!Jun!27;133(26):2776>2789.!
>!Laurent!C,!Delas!A,!Gaulard!P,!et!al.!Breast!implant>associated!anaplastic!large!cell!lymphoma:!two!
distinct!clinicopathological!variants!with!different!outcomes.!Ann!Oncol.!2016!Feb;27(2):306>14.!!
>! Laurent! C,! Nicolae! A,! Laurent! C,! et! al.! Gene! alterations! in! epigenetic! modifiers! and! JAK>STAT!
signaling! are! frequent! in! breast! implant>associated! ALCL.! Blood.! 2020! Jan! 30;135(5):360>370.! >!
Broccoli! A,! Zinzani! PL.! Peripheral! T>cell! lymphoma,! not! otherwise! specified.! Blood.! 2017! Mar!
2;129(9):1103>1112.!
>!Amador!C,!Greiner!TC,!Heavican!TB,!et!al.!Reproducing!the!molecular!subclassification!of!peripheral!
T>cell!lymphoma>NOS!by!immunohistochemistry.!!Blood.!2019!Dec!12;134(24):2159>2170.!!
>!Heavican!TB,!Bouska!A,!Yu!J,!et!al.!Genetic!drivers!of!oncogenic!pathways!in!molecular!subgroups!of!
peripheral! T>cell! lymphoma.! Blood.! 2019! Apr! 11;133(15):1664>1676.! doi:! 10.1182/blood>2018>09>
872549.!Epub!2019!Feb!19.!!!
>! Roberti! A,! Dobay! MP,! Bisig! B,! et! al.! Type! II! enteropathy>associated! T>cell! lymphoma! features! a!
unique!genomic!profile!with!highly!recurrent!SETD2!alterations.!Nat!Commun.!2016!Sep!7;7:12602.!
doi:!10.1038/ncomms12602.!PubMed!PMID:!27600764.!
>!Moffitt!AB,!Ondrejka!SL,!McKinney!M,!et!al.!Enteropathy>associated!T!cell!lymphoma!subtypes!are!
characterized!by!loss!of!function!of!SETD2.!J!Exp!Med.!2017!May!1;214(5):1371>1386.!!
>!Travert!M,!Huang!Y,!de!Leval!L,!et!al.!Molecular!features!of!hepatosplenic!T>cell!lymphoma!unravels!
potential!novel!therapeutic!targets.!Blood.!2012!Jun!14;119(24):5795>806.!
>! McKinney! M,! Moffitt! AB,! Gaulard! P,! et! al.! The! Genetic! Basis! of! Hepatosplenic! T>cell! Lymphoma.!
Cancer!Discov.!2017!Apr;7(4):369>379.!
SCIENTIFIC PROGRAMME
SESSION I
HODGKIN’S DISEASE
DEBATE I
IS THERE STILL A ROLE
FOR COMBINED MODALITY
THERAPY FOR EARLY
STAGE CHL?
SESSION II
T-CELL LYMPHOMA
ROUNDTABLE I
FUTURE DIRECTIONS IN
T-CELL LYMPHOMA
SESSION III
FOLLICULAR LYMPHOMA
DEBATE II
CAN WE AVOID
CHEMOTHERAPY IN
THE MANAGEMENT OF
FOLLICULAR LYMPHOMA?
SESSION IV
RARE LYMPHOMAS –
MARGINAL ZONE
LYMPHOMA AND
WALDENSTRÖM M
ACROGLOBULINEMIA
ROUNDTABLE II – WHERE
TO GO IN RARE B-CELL
LYMPHOMAS
SESSION V
MANTLE CELL LYMPHOMA
SESSION VI
DIFFUSE LARGE B-CELL
LYMPHOMA
DEBATE III
DO WE STILL NEED ASCT
IN MCL?
SESSION VII
NOVEL THER APEUTIC
CONCEPTS IN B-CELL
LYMPHOMAS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
DISCLOSURES